Year in review on osteoarthritis (2023)-Reference-Cited by-同舟云学术

Year in review on osteoarthritis (2023)

Published:2024 Issue:1 Volume:2 Page:3-9
ISSN:2949-9860
Container-title:Journal of Integrative Medicine and Research
language:en
Short-container-title:

Author:

Dhanekula Phanidhar¹,Maikap Debashis¹

Affiliation:

1. Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, Odisha, India

Abstract

Abstract: Significant strides persist in advancing our comprehension of the diverse dimensions of osteoarthritis (OA) biology. In this overview, we delineate the notable breakthroughs in this domain and the headway achieved in the pursuit of therapeutic development over the preceding year. This examination spotlights pertinent publications identified through a PubMed search, encompassing the timeframe from late November 2022 to late November 2023. Advancements in unraveling the cellular and molecular mechanisms underlying various facets of OA biology are uncovering innovative therapeutic targets for modifying the course of the disease.

Publisher

Medknow

Reference20 articles.

1. Osteoarthriris year in review 2023:genetics, genomics, and epigenetics;Waheed;Osteoarthritis Cartilage,2023

2. Exploring the feasibility of circulating miRNAs as diagnostic and prognostic biomarkers in osteoarthritis:Challenges and opportunities;Felekkis;Int J Mol Sci,2023

3. Osteoarthritis year in review 2023:Biology;Roelofs;Osteoarthritis Cartilage,2023

4. Osteomodulin downregulation is associated with osteoarthritis development;Zappia;Bone Res,2023

5. Activated macrophage membrane-coated nanoparticles relieve osteoarthritis-induced synovitis and joint damage;Zhou;Biomaterials,2023